Mycophenolate Mofetil Hydrochloride Patent Expiration

Mycophenolate Mofetil Hydrochloride was first introduced by Roche Palo Alto Llc in its drug Cellcept on Aug 12, 1998. 9 different companies have introduced drugs containing Mycophenolate Mofetil Hydrochloride.


Mycophenolate Mofetil Hydrochloride Patents

Given below is the list of patents protecting Mycophenolate Mofetil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cellcept US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof Sep 15, 2013

(Expired)

Roche Palo


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Mycophenolate Mofetil Hydrochloride Generics

Several generic applications have been filed for Mycophenolate Mofetil Hydrochloride. The first generic version for Mycophenolate Mofetil Hydrochloride was by Endo Operations Ltd and was approved on Oct 28, 2016. And the latest generic version is by Bpi Labs Llc and was approved on Jun 1, 2023.

Given below is the list of companies who have filed for Mycophenolate Mofetil Hydrochloride generic.


1. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Mar 31, 2017


2. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Discontinued INJECTION N/A Mar 5, 2021


3. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Feb 28, 2017


4. BPI LABS

Bpi Labs Llc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Bpi Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Jun 1, 2023


5. STERISCIENCE

Steriscience Pte Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Steriscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Dec 23, 2022


6. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Jan 15, 2021


7. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Oct 28, 2016


8. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL injectable Prescription INJECTION AP Aug 31, 2017